Entering text into the input field will update the search result below

Stephen Willard is the new CEO of NRx Pharmaceuticals

Jul. 13, 2022 7:23 AM ETNRx Pharmaceuticals, Inc. (NRXP)By: Deepa Sarvaiya, SA News Editor
  • NRx Pharmaceuticals (NASDAQ:NRXPappoints extensive experienced in law, finance, and management of public and private biotechnology companies Stephen Willard as its CEO and a member of the company's board of directors.
  • The company's interim CEO, Robert Besthof, will continue to support the company and return to his roles as Head of Operations and Chief Commercial Officer.
  • Most recently, Mr. Willard served as CEO of Cellphire Therapeutics.

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

About NRXP

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
NRx Pharmaceuticals, Inc.
Antibe Therapeutics Inc.
Charlotte's Web Holdings, Inc.
Numinus Wellness Inc.
Purple Biotech Ltd.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.